Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CLYM
CLYM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CLYM News
Analysis of Biotech Companies' Stock Performance
2d ago
NASDAQ.COM
Climb Bio Shares CLYM116 Clinical Data and Future Plans
Jun 05 2026
Newsfilter
Climb Bio Secures $110M in Private Placement
Apr 28 2026
seekingalpha
Climb Bio Secures $110M in Private Placement
Apr 28 2026
seekingalpha
Climb Bio Secures $110M in Private Placement
Apr 28 2026
seekingalpha
Climb Bio Secures $110M in Private Placement
Apr 28 2026
seekingalpha
Climb Bio Announces R&D Webcast for Budoprutug
Apr 08 2026
Newsfilter
Climb Bio Receives FDA Fast Track Designation for Budoprutug
Apr 07 2026
Newsfilter
Climb Biopress Reports Q4 Earnings and Financial Position
Mar 05 2026
seekingalpha
Wall Street Analysts Adjust Ratings
Feb 13 2026
Benzinga
Top High Flyer Healthcare Stocks Revealed
Feb 02 2026
seekingalpha
GE Vernova Expected to Surge by 33%? Check Out 10 Leading Analyst Predictions for Thursday
Dec 18 2025
Benzinga
Promising Data on the Horizon: Can 2026 Results Propel Climb Bio Forward?
Dec 15 2025
NASDAQ.COM
Climb Bio Appoints Adam Villa as Senior Vice President of Technical Operations and Ashley Jones as Senior Vice President of People and Workforce Strategy
Oct 21 2025
Newsfilter
Climb Bio's Lead Drug Candidate Offers Significant Long-Term Potential for Small-Cap Biotech
Oct 16 2025
Benzinga
Celestica Analyst Starts Coverage Optimistically; Check Out Thursday's Top 5 Initiations
Oct 16 2025
Benzinga
Show More News
